Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation
JAMA Pediatrics · 01.06.2026 · 180 (6) · 639
DOI: 10.1001/jamapediatrics.2026.0015 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JAMA Pediatrics, erschienen am 01.06.2026. Verfasst von Matthew L Friedman und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Indiana University School of Medicine, Indianapolis. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Brain Injuries, Glial Fibrillary Acidic Protein, Neurofilament Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NINDS NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance Timely identification of acute brain injury (ABI) in children receiving extracorporeal membrane oxygenation (ECMO) support is critical for early neuroprotective interventions.
Objectives
To determine if elevations in plasma glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), and tau levels in children receiving ECMO precede new ABI confirmed by neuroimaging, and if they are associated with mortality and functional outcomes. Design, Setting, and Participants This was a prospective observational cohort study conducted from 2019 to 2023, with 18-month follow-up completed in 2025. Children aged 2 days to younger than 18 years at ECMO cannulation were recruited from 11 US children’s hospitals. Study data were analyzed from May to August 2025. Exposures GFAP, NfL, and tau measured in plasma samples collected serially during the ECMO course. Main Outcomes and Measures Unfavorable short-term outcome was a composite of in-hospital mortality or discharge Pediatric Cerebral Performance Category score of 3 or greater with decline of at least 1 point from baseline. Unfavorable long-term outcome was a composite of mortality or Vineland Adaptive Behavior Scales, third edition, composite score less than 85 at 18 months after ECMO.
Results
This study included 219 participants (224 ECMO courses; 1089 serial blood samples). Median age was 11 months (IQR, 30 days-9 years), and 121 (54%) were male. Among 60 ECMO courses with new ABI during the ECMO course, GFAP and NfL levels increased significantly, by 6.4% (95% CI, 1.4%-11.6%) and 16.1% (95% CI, 10.5%-22.0%), respectively, for each 24 hours preceding neuroimaging diagnosis of new ABI. Geometric means for GFAP, NfL, and tau were all significantly higher in those with unfavorable vs favorable outcome at hospital discharge for both the first sample receiving ECMO and peak levels during ECMO support. A 2-fold increase in GFAP and NfL levels from first sample receiving ECMO was significantly associated with unfavorable outcome after adjusting for baseline GFAP and NfL levels, age, and ECMO indication (GFAP adjusted hazard ratio [aHR], 1.48; 95% CI, 1.22-1.79; NfL aHR, 1.43; 95% CI, 1.14-1.79). Similar models for tau showed no significant association with outcomes. Conclusions and Relevance Results suggest that GFAP and NfL may be promising candidates for real-time neurologic monitoring in children receiving ECMO and may aid in diagnosis, association with outcomes, and potentially guiding neuroprotective strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis.
- Department of Pediatrics, UT Southwestern, Dallas, Texas.
- Division of Pediatric Critical Care Medicine, Mattel Children's Hospital, University of California Los Angeles.
- Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia, Philadelphia.
- Department of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, California.
- Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Friedman, M. L., Bell, M. J., Brooks, B. A., Himebauch, A. S., Kamerkar, A., LaRovere, K., Loftis, L. L., Pineda, J. A., Said, A., Sandhu, H. S., Stengelin, M., Demos, C., Wainwright, M. S., West, A. N., Barnes, A., Everett, A. D., Felling, R. J., Hong, S. J., Roem, J. L., …, & Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network (2026). Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation. JAMA Pediatrics, 180(6), 639. https://doi.org/10.1001/jamapediatrics.2026.0015
Vancouver
Friedman ML, Bell MJ, Brooks BA, Himebauch AS, Kamerkar A, LaRovere K, et al. Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation. JAMA Pediatrics. 2026;180(6):639. doi:10.1001/jamapediatrics.2026.0015
BibTeX
@article{Friedman2026,
author = {Friedman, Matthew L and Bell, Michael J and Brooks, Bonnie A and Himebauch, Adam S and Kamerkar, Asavari and LaRovere, Kerri and Loftis, Laura L and Pineda, Jose A and Said, Ahmed and Sandhu, Hitesh S and Stengelin, Martin and Demos, Catherine and Wainwright, Mark S and West, Alina N and Barnes, Allan and Everett, Allen D and Felling, Ryan J and Hong, Sue J and Roem, Jennifer L and Salorio, Cynthia F and Ng, Derek K and Bembea, Melania M and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network},
title = {Plasma Biomarkers of Brain Injury in Critically Ill Children Receiving Extracorporeal Membrane Oxygenation},
journal = {JAMA Pediatrics},
year = {2026},
volume = {180},
number = {6},
pages = {639},
doi = {10.1001/jamapediatrics.2026.0015}
}
EUVIMED